MWA
CRVO icon

Medallion Wealth Advisors’s CervoMed CRVO Stock Holding History

Medallion Wealth Advisors’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$16 – 1128
2025
Q4 		$16 Hold
2
– – ﹤0.01% 1114
2025
Q3 		$16 Hold
2
– – ﹤0.01% 1099
2025
Q2 		$12 Hold
2
– – ﹤0.01% 1092
2025
Q1 		$20 Hold
2
– – ﹤0.01% 1065
2024
Q4 		$5 Buy
+2
New +$19 ﹤0.01% 1020

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Medallion Wealth Advisors's CRVO Position: Q1 2026 in Review

Medallion Wealth Advisors sold out of CervoMed (CRVO) in Q1 2026, closing a stake of 2 shares — an estimated $16 sold.

Medallion Wealth Advisors first reported a position in CRVO in Q4 2024 and held it in 5 quarters. The position peaked at $20 in Q1 2025. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • Medallion Wealth Advisors reported no remaining CervoMed position as of Q1 2026 after selling out during the quarter.
  • Medallion Wealth Advisors sold 2 CervoMed shares in Q1 2026, an estimated $16.
  • Medallion Wealth Advisors first reported a position in CervoMed in Q4 2024 and held it in 5 quarters.
  • Medallion Wealth Advisors's CervoMed position peaked at $20 in Q1 2025.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Medallion Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.